Clementina Misuraca

Clementina Misuraca

Auto-generated profile, based on publicly available information

Clementina Misuraca

Pulmonary Rehabilitation Unit, INRCA-IRCCS, Casatenovo, Italy

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
EPElisa Pancini
Elisa Pancini
AFAlessia Fumagalli
Alessia Fumagalli
SMSveva Maggiolini
Sveva Maggiolini
CMClementina Misuraca
Clementina Misuraca
DNDavide Negri
Davide Negri
DVDaniela Villani
Daniela Villani
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Chronic respiratory diseases (CRDs) are widespread pathologies that cause non-reversible airflow limitations as well as a variety of extrapulmonary adverse effects. For these reasons, these pathologies are related to frequent hospitalizations and, consequently, high levels of anxiety, depression, and stress. In this respect, relaxation in Virtual Reality (VR) integrated with savoring, which is the ability to generate and amplify positive emotions, can be used to increase well-being and relaxation in CRDs patients. Objective: This pilot randomized controlled trial aimed to investigate the effectiveness of a two-week VR-based relaxation intervention integrated with savoring in CRDs patients in increasing emotional and psychological well-being, positive emotions, relaxation, oxygen saturation levels (SpO2) and decreasing negative emotions. Methods: This study involved 45 hospitalized CRDs patients from the Pulmonary Rehabilitation Unit of IRCCS INRCA Casatenovo. Alongside traditional pulmonary rehabilitation, the experimental group (N = 23) took part in the four-session VR-based intervention, while the active control group (N = 22) listened to relaxing music. In each session, the experimental group experienced a relaxing virtual scenario followed by a savoring exercise. Both groups filled out the self-reported questionnaires before the intervention (T0), after (T1), and in the one-month follow-up (T2), and before and after each session. The experimental group's VR acceptance and sense of presence were also measured. Results: Regarding the primary outcomes, taking T0 and T1 into account, repeated measures ANCOVAs revealed a significant increase for the experimental group in emotional and psychological well-being, positive emotions, relaxation, and a significant decrease in negative emotions compared to the control group. The psychological changes were maintained at T2. Concerning secondary outcomes, patients reported high VR acceptance and sense of presence. Conclusions: These results suggest that relaxation VR integrated with savoring can promote well-being and reduce clinical symptoms not only in the post-intervention, but also in the long term. Indeed, savoring can amplify the positive effects of relaxing VR and help patients to focus and amplify their positive experiences, thus counteracting the negative psychological consequences of CRDs. Clinical Trial: anzctr.org, ACTRN12624000435583; https://www.anzctr.org.au/ACTRN12624000435583.aspx (retrospectively registered). This study was approved by the Ethics Committee of the IRCCS INRCA Casatenovo but for administrative issues the trial registration was no completed prospectively. The registration was therefore completed retrospectively before data analysis and paper writing.

18 September 2026 in Thorax
Verified
Journal Article
Closed access
PDF file
Mauro ManiscalcoMauro Maniscalco
Mauro Maniscalco
CCClaudio Candia
Claudio Candia
GFGiuseppe Fiorentino
Giuseppe Fiorentino
LBLuca Nicola Cesare Bianchi
Luca Nicola Cesare Bianchi
LFLaura Fagetti
Laura Fagetti
MVMichele Vitacca
Michele Vitacca
Background: Pulmonary rehabilitation (PR) is the cornerstone of non-pharmacological treatment for chronic obstructive pulmonary disease (COPD), yet fatigue often persists despite rehabilitation. We conducted a multicentre, randomised, double-blind, placebo-controlled trial to evaluate whether oral L-arginine plus liposomal vitamin C improves fatigue in patients with advanced COPD and chronic respiratory failure (CRF) undergoing PR. Methods: Consecutive patients with stable COPD and CRF receiving long-term oxygen therapy were randomised to L-arginine/liposomal vitamin C or placebo during a standardised 28-day PR programme. Fatigue was assessed using the Fatigue Severity Scale (FSS). The primary analysis used a longitudinal linear mixed-effects model including repeated FSS measurements, treatment group, time, treatment-by-time interaction and prespecified covariates. Secondary outcomes included 6 min walk distance, sit-to-stand test, handgrip strength, COPD Assessment Test and modified Medical Research Council dyspnoea score. Results: 98 participants were randomised. A significant difference was found in FSS changes between groups (mean difference −0.90; 95% CI −1.50 to −0.29; p=0.004), confirmed by the adjusted treatment-by-time interaction analysis (adjusted between-group difference −0.72; 95% CI −1.25 to −0.20; p=0.009). The point estimate exceeded the prespecified minimal clinically important difference (0.6 points). A higher proportion of participants achieved an FSS score <4 in the intervention group versus placebo group (57% vs 36%; p=0.059). No significant between-group differences were observed for secondary outcomes. Conclusions: In patients with COPD and CRF undergoing PR, adjunctive oral L-arginine plus liposomal vitamin C was associated with a greater reduction in perceived fatigue, without significant improvements in functional or patient-reported secondary outcomes. Trial registration number: NCT06439875 .